Free Trial

Perrigo Company plc (NYSE:PRGO) Shares Sold by Bank of Montreal Can

Perrigo logo with Medical background

Bank of Montreal Can trimmed its holdings in Perrigo Company plc (NYSE:PRGO - Free Report) by 86.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,003 shares of the company's stock after selling 125,471 shares during the quarter. Bank of Montreal Can's holdings in Perrigo were worth $514,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Franklin Resources Inc. purchased a new position in shares of Perrigo during the third quarter valued at approximately $3,717,000. Barclays PLC boosted its holdings in Perrigo by 44.8% in the third quarter. Barclays PLC now owns 120,502 shares of the company's stock worth $3,160,000 after acquiring an additional 37,268 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Perrigo by 65.1% in the third quarter. JPMorgan Chase & Co. now owns 541,000 shares of the company's stock worth $14,190,000 after acquiring an additional 213,221 shares during the last quarter. Virtu Financial LLC bought a new position in shares of Perrigo during the third quarter valued at $909,000. Finally, Access Investment Management LLC bought a new position in Perrigo in the 4th quarter worth about $7,989,000. 95.91% of the stock is owned by hedge funds and other institutional investors.

Perrigo Stock Up 1.5 %

PRGO traded up $0.37 on Friday, hitting $25.26. The company had a trading volume of 1,145,059 shares, compared to its average volume of 1,524,648. Perrigo Company plc has a 12-month low of $23.14 and a 12-month high of $33.46. The stock has a market capitalization of $3.45 billion, a price-to-earnings ratio of -21.59 and a beta of 0.49. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. The stock has a fifty day moving average price of $26.52 and a 200-day moving average price of $26.05.

Perrigo (NYSE:PRGO - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported $0.93 EPS for the quarter, beating the consensus estimate of $0.92 by $0.01. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The business had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.20 billion. Analysts predict that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th were issued a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.59%. This is a boost from Perrigo's previous quarterly dividend of $0.28. The ex-dividend date of this dividend was Friday, March 7th. Perrigo's dividend payout ratio is presently -92.80%.

Analyst Upgrades and Downgrades

PRGO has been the topic of several recent analyst reports. StockNews.com downgraded Perrigo from a "buy" rating to a "hold" rating in a research note on Wednesday, February 19th. Piper Sandler lowered shares of Perrigo from an "overweight" rating to a "neutral" rating and dropped their price target for the stock from $34.00 to $27.00 in a research report on Monday, January 6th. Finally, Argus lowered shares of Perrigo from a "buy" rating to a "hold" rating in a report on Tuesday, January 14th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $33.00.

Check Out Our Latest Report on Perrigo

Insider Transactions at Perrigo

In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of the stock in a transaction on Monday, March 10th. The stock was sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the transaction, the executive vice president now owns 33,666 shares in the company, valued at approximately $923,795.04. This represents a 18.81 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.70% of the company's stock.

About Perrigo

(Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Further Reading

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Should You Invest $1,000 in Perrigo Right Now?

Before you consider Perrigo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.

While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines